Skip to content

Coronavirus

These Biotechs Are Awaiting FDA Decisions In January

While the most important decisions made by the FDA in December were undoubtedly the Emergency Use Authorizations for two COVID-19 vaccines, the month also saw a number of firsts on the regulatory front, including the authorization of the first test allowing for at-home collection of patient samples to detect both COVID-19 and influenza A and B. Now, today’s article takes… 

Could These 2 Ultra-Risky Biotech Stocks Make Investors Ultra Wealthy?

Both of the stocks highlighted in today’s article are clinical-stage biotechs, both are developing products to address the coronavirus pandemic (a vaccine in one case and a therapeutic in the other) – and both are “ultra-risky”. So what are the chances that either – or both – of these two ultra-risky stocks could make investors ultra wealthy? For more on… 

This Little-Known Biotech’s Blood Plasma-Based Coronavirus Therapy Could Soon Bring It A Lot Of Attention

Of all the companies working on the development of potential COVID-19 vaccines and therapeutics, the one highlighted in today’s article – a small Israel-based biotech that specializes in blood plasma-based treatments – is one of the least well-known. However, given that plasma-based therapies have already been shown to be effective in treating severe cases of COVID-19, this company could start… 

The Risky Business Of Chasing Vaccine Producers

It’s the most popular investing theme this year: COVID-19 vaccine producers. However, the recent reversal of fortunes for the stock of one biotech firm – whose stock had nearly tripled since the beginning of March when the firm announced it was working on a vaccine for the novel coronavirus – illustrates the risk involved with “chasing vaccine hype”. For more,… 

“Gut Check”: How One Man’s Extremely Bad Luck Is A Wake-Up Call For Retirees

“This is very disconcerting and very bad timing,” says Tracy Donaldson, a newly retired Floridian who had the extremely bad luck of retiring the same week the Dow dropped significantly on coronavirus fears. But while Donaldson’s guaranteed pension and Social Security mean he’ll be fine even in the event of a lengthy downturn, many retirees may find themselves in a…